Showing results (761-770 of 807) with videos related to
Sort By:
Pageof 81
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2014
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinomaC H Chung, J W Lee, R J Slebos, et al.Therapeutic Advances in Musculoskeletal Disease|April 14, 2026
Effects of achieving simple disease activity index remission on joint space outcomes progression in early rheumatoid arthritis: an exploratory study using high-resolution peripheral quantitative computed tomographyQihan Wu, Ho So, Isaac T Cheng, et al.Oncogenesis|April 5, 2016
BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancerC Gong, S Yao, A R Gomes, et al.Annals of the Rheumatic Diseases|April 12, 2026
Differentiation of physiological from pathological bone erosions in rheumatoid arthritis: an 8-year HR-pQCT study of the second metacarpal headXianfeng Yan, Isaac T Cheng, Ho So, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2017
Immunologic regulatory effects of human umbilical cord blood-derived mesenchymal stem cells in a murine ovalbumin asthma modelS-Y Kang, D-E Park, W-J Song, et al.Antimicrobial Agents and Chemotherapy|February 13, 2001
SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2R W Buckheit, K Watson, V Fliakas-Boltz, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
A humanized anti--4-1BB monoclonal antibody suppresses antigen-induced humoral immune response in nonhuman primatesH J Hong, J W Lee, S S Park, et al.Bone Marrow Transplantation|March 26, 2014
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALLS-H Shin, J-H Yoon, S-A Yahng, et al.Bone Marrow Transplantation|August 12, 2014
Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantationJ-H Yoon, H-J Kim, J-W Kim, et al.Bone Marrow Transplantation|June 28, 2016
Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioningS H Shin, Y W Jeon, J H Yoon, et al.Pageof 81